{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:48Z","timestamp":1787021268110,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03195-4","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:39:02Z","timestamp":1753832342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influence of Hydrophobic Ion Pairing on Formulation Performance of Liraglutide in PLGA Microspheres"],"prefix":"10.1208","volume":"26","author":[{"given":"Jyotsna G.","family":"Vitore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varla","family":"Yalamanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra Singh","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Rojekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhwani","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derajram","family":"Benival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"17","key":"3195_CR1","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"key":"3195_CR2","doi-asserted-by":"publisher","first-page":"110708","DOI":"10.1016\/j.biopha.2020.110708","volume":"131","author":"S Padhi","year":"2020","unstructured":"Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131:110708.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3195_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/S2213-8587(24)00127-X","volume":"12","author":"M Abdul-Ghani","year":"2024","unstructured":"Abdul-Ghani M, Maffei P, DeFronzo RA. Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes. Lancet Diabetes Endocrinol. 2024;12(9):674\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3195_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.biopha.2018.08.088","volume":"108","author":"D Sharma","year":"2018","unstructured":"Sharma D, Verma S, Vaidya S, Kalia K, Tiwari V. Recent updates on GLP-1 agonists: current advancements & challenges. Biomed Pharmacother. 2018;108:952\u201362.","journal-title":"Biomed Pharmacother"},{"issue":"7544","key":"3195_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S0140-6736(68)92103-X","volume":"291","author":"KR Mansford","year":"1968","unstructured":"Mansford KR, Opie L. Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin or by alloxan. Lancet. 1968;291(7544):670\u20131.","journal-title":"Lancet"},{"key":"3195_CR6","doi-asserted-by":"publisher","first-page":"32714","DOI":"10.1038\/srep32714","volume":"6","author":"J Gu","year":"2016","unstructured":"Gu J, Meng X, Guo Y, Wang L, Zheng H, Liu Y, et al. The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials. Sci Rep. 2016;6:32714.","journal-title":"Sci Rep"},{"issue":"3","key":"3195_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/jcm3030923","volume":"3","author":"Y Saisho","year":"2014","unstructured":"Saisho Y. Importance of beta cell function for the treatment of type 2 diabetes. J Clin Med. 2014;3(3):923.","journal-title":"J Clin Med"},{"issue":"21","key":"3195_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281(21):2005\u201312.","journal-title":"JAMA"},{"issue":"6","key":"3195_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tips.2016.03.004","volume":"37","author":"S Prasad","year":"2016","unstructured":"Prasad S, Gupta SC, Aggarwal BB. Serendipity in cancer drug discovery: rational or coincidence? Trends Pharmacol Sci. 2016;37(6):435\u201350.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"3195_CR10","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1463-1326.2008.00853.x","volume":"10","author":"K Aaboe","year":"2008","unstructured":"Aaboe K, Krarup T, Madsbad S, Holst JJ. GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab. 2008;10(11):994\u20131003.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"3195_CR11","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1210\/en.2002-220405","volume":"143","author":"L Farilla","year":"2002","unstructured":"Farilla L, Hongxiang H, Bertolotto C, Kang E, Bulotta A, Mario UDI, et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 2002;143(11):4397\u2013408.","journal-title":"Endocrinology"},{"key":"3195_CR12","unstructured":"Victoza | European Medicines Agency (EMA)."},{"key":"3195_CR13","unstructured":"Liraglutide (marketed as Victoza) Information | FDA."},{"key":"3195_CR14","doi-asserted-by":"publisher","first-page":"122585","DOI":"10.1016\/j.ijpharm.2023.122585","volume":"634","author":"DK Jakhar","year":"2023","unstructured":"Jakhar DK, Vishwakarma VK, Singh R, Jadhav K, Shah S, Arora T, et al. Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials. Int J Pharm. 2023;634:122585.","journal-title":"Int J Pharm"},{"key":"3195_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.addr.2018.07.009","volume":"130","author":"M Yu","year":"2018","unstructured":"Yu M, Benjamin MM, Srinivasan S, Morin EE, Shishatskaya EI, Schwendeman SP, et al. Battle of GLP-1 delivery technologies. Adv Drug Deliv Rev. 2018;130:113.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3195_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1464-5491.2009.02666.x","volume":"26","author":"M Marre","year":"2009","unstructured":"Marre M, Shaw J, Br\u00e4ndle M, Bebakar WMW, Kamaruddin NA, Strand J, et al. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabet Med. 2009;26(3):268.","journal-title":"Diabet Med"},{"issue":"9","key":"3195_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1592\/phco.31.9.896","volume":"31","author":"EM Sisson","year":"2011","unstructured":"Sisson EM. Liraglutide: clinical pharmacology and considerations for therapy. Pharmacother J Hum Pharmacol Drug Ther. 2011;31(9):896\u2013911.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"SUPPL. 167","key":"3195_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1742-1241.2010.02498.x","volume":"64","author":"GE Peterson","year":"2010","unstructured":"Peterson GE, Pollom RD. Liraglutide in clinical practice: dosing, safety and efficacy. Int J Clin Pract. 2010;64(SUPPL. 167):35\u201343.","journal-title":"Int J Clin Pract"},{"key":"3195_CR19","doi-asserted-by":"publisher","first-page":"106040","DOI":"10.1016\/j.ejps.2021.106040","volume":"167","author":"M Rabiei","year":"2021","unstructured":"Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, et al. Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity. Eur J Pharm Sci. 2021;167:106040.","journal-title":"Eur J Pharm Sci"},{"key":"3195_CR20","doi-asserted-by":"publisher","first-page":"114862","DOI":"10.1016\/j.addr.2023.114862","volume":"198","author":"AB Jindal","year":"2023","unstructured":"Jindal AB, Bhide AR, Salave S, Rana D, Benival D. Long-acting parenteral drug delivery systems for the treatment of chronic diseases. Adv Drug Deliv Rev. 2023;198:114862.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3195_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0378-5173(94)90103-1","volume":"105","author":"J Zuidema","year":"1994","unstructured":"Zuidema J, Kadir F, Titulaer HAC, Oussoren C. Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II). Int J Pharm. 1994;105(3):189\u2013207.","journal-title":"Int J Pharm"},{"key":"3195_CR22","doi-asserted-by":"publisher","first-page":"121875","DOI":"10.1016\/j.ijpharm.2022.121875","volume":"622","author":"M Kim","year":"2022","unstructured":"Kim M, Kim JH, Kim S, Maharjan R, Kim NA, Jeong SH. New long-acting injectable microspheres prepared by IVL-DrugFluidic\u2122 system: 1-month and 3-month in vivo drug delivery of leuprolide. Int J Pharm. 2022;622:121875.","journal-title":"Int J Pharm"},{"key":"3195_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","volume":"304","author":"K Park","year":"2019","unstructured":"Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, et al. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J Control Release. 2019;304:125\u201334.","journal-title":"J Control Release"},{"key":"3195_CR24","doi-asserted-by":"crossref","unstructured":"Lagreca E, Onesto V, Di Natale C, La Manna S, Netti PA, Vecchione R. Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Vol. 9, Progress in Biomaterials. Springer; 2020. p. 153\u201374.","DOI":"10.1007\/s40204-020-00139-y"},{"key":"3195_CR25","doi-asserted-by":"publisher","first-page":"104762","DOI":"10.1016\/j.jddst.2023.104762","volume":"87","author":"MA Pawar","year":"2023","unstructured":"Pawar MA, Abadi LF, Rojekar SV, Yawalkar AN, Kulkarni SS, Vavia PR. Tenofovir alafenamide fumarate loaded long-acting microsphere for HIV pre-exposure prophylaxis. J Drug Deliv Sci Technol. 2023;87:104762.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"3195_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ijpharm.2015.10.057","volume":"496","author":"M Iqbal","year":"2015","unstructured":"Iqbal M, Zafar N, Fessi H, Elaissari A. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharm. 2015;496(2):173\u201390.","journal-title":"Int J Pharm"},{"issue":"3","key":"3195_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-024-02760-7","volume":"25","author":"S Longre","year":"2024","unstructured":"Longre S, Rana D, Rangra S, Jindal AB, Salave S, Vitore J, et al. Quality-by-design based development of doxycycline hyclate-loaded polymeric microspheres for prolonged drug release. AAPS PharmSciTech. 2024;25(3):1\u201326.","journal-title":"AAPS PharmSciTech"},{"key":"3195_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ejpb.2019.09.022","volume":"144","author":"J Liu","year":"2019","unstructured":"Liu J, Xu Y, Liu Z, Ren H, Meng Z, Liu K, et al. A modified hydrophobic ion-pairing complex strategy for long-term peptide delivery with high drug encapsulation and reduced burst release from PLGA microspheres. Eur J Pharm Biopharm. 2019;144:217\u201329.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3195_CR29","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1021\/acsnano.0c01835","volume":"14","author":"DJ Kozuch","year":"2020","unstructured":"Kozuch DJ, Ristroph K, Prud\u2019Homme RK, Debenedetti PG. Insights into hydrophobic ion pairing from molecular simulation and experiment. ACS Nano. 2020;14(5):6097\u2013106.","journal-title":"ACS Nano"},{"issue":"3","key":"3195_CR30","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1208\/pt060361","volume":"6","author":"F Kang","year":"2005","unstructured":"Kang F, Singh J. Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits. AAPS PharmSciTech. 2005;6(3):E487\u201394.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3195_CR31","doi-asserted-by":"publisher","first-page":"14451","DOI":"10.3390\/molecules200814451","volume":"20","author":"E Moghimipour","year":"2015","unstructured":"Moghimipour E, Ameri A, Handali S. Absorption-enhancing effects of bile salts. Molecules. 2015;20(8):14451.","journal-title":"Molecules"},{"key":"3195_CR32","unstructured":"2.4 Docusate sodium | Therapeutic Goods Administration (TGA)."},{"issue":"2","key":"3195_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/01926230701226575","volume":"35","author":"A Jacobs","year":"2007","unstructured":"Jacobs A, Seifried A. Food and drug administration, center for drug evaluation and research. Toxicol Pathol. 2007;35(2):323\u20134.","journal-title":"Toxicol Pathol"},{"issue":"11","key":"3195_CR34","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1039\/C9NA00308H","volume":"1","author":"KD Ristroph","year":"2019","unstructured":"Ristroph KD, Prud\u2019homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207.","journal-title":"Nanoscale Adv"},{"key":"3195_CR35","doi-asserted-by":"publisher","first-page":"105737","DOI":"10.1016\/j.ejps.2021.105737","volume":"159","author":"DJ Brayden","year":"2021","unstructured":"Brayden DJ, Stuettgen V. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays. Eur J Pharm Sci. 2021;159:105737.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"3195_CR36","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11095-006-0180-2","volume":"23","author":"C Bouissou","year":"2006","unstructured":"Bouissou C, Rouse JJ, Price R, Van Der Walle CF. The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release. Pharm Res. 2006;23(6):1295\u2013305.","journal-title":"Pharm Res"},{"key":"3195_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jconrel.2021.08.060","volume":"338","author":"S Bashyal","year":"2021","unstructured":"Bashyal S, Seo JE, Choi YW, Lee S. Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach. J Control Release. 2021;338:644\u201361.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"3195_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2017.02.019","volume":"520","author":"J Griesser","year":"2017","unstructured":"Griesser J, Het\u00e9nyi G, Moser M, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm. 2017;520(1\u20132):267\u201374.","journal-title":"Int J Pharm"},{"issue":"1","key":"3195_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-09384-6","volume":"12","author":"SI Abd-El Hafeez","year":"2022","unstructured":"Abd-El Hafeez SI, Eleraky NE, Hafez E, Abouelmagd SA. Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers. Sci Rep. 2022;12(1):1\u201314.","journal-title":"Sci Rep"},{"issue":"11","key":"3195_CR40","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1039\/C9NA00308H","volume":"1","author":"KD Ristroph","year":"2019","unstructured":"Ristroph KD, Prud\u2019homme RK. Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers. Nanoscale Adv. 2019;1(11):4207\u201337.","journal-title":"Nanoscale Adv"},{"issue":"3","key":"3195_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/10837450.2012.737806","volume":"18","author":"R Gaudana","year":"2013","unstructured":"Gaudana R, Gokulgandhi M, Khurana V, Kwatra D, Mitra AK. Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme. Pharm Dev Technol. 2013;18(3):752\u20139.","journal-title":"Pharm Dev Technol"},{"key":"3195_CR42","doi-asserted-by":"publisher","first-page":"106324","DOI":"10.1016\/j.jddst.2024.106324","volume":"102","author":"M Truszkowska","year":"2024","unstructured":"Truszkowska M, Stengel D, Schmidt MR, Marx F, Coraca-Huber D, Bernkop-Schn\u00fcrch A. Synergistic antimicrobial effect of daptomycin and ethyl lauroyl arginate containing self-emulsifying drug delivery system against bacterial infections. J Drug Deliv Sci Technol. 2024;102:106324.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"3195_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijpharm.2015.04.075","volume":"489","author":"RD Vaishya","year":"2015","unstructured":"Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles. Int J Pharm. 2015;489(1\u20132):237\u201345.","journal-title":"Int J Pharm"},{"key":"3195_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejps.2016.06.018","volume":"92","author":"J Wu","year":"2016","unstructured":"Wu J, Williams GR, Branford-White C, Li H, Li Y, Zhu LM. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation. Eur J Pharm Sci. 2016;92:28\u201338.","journal-title":"Eur J Pharm Sci"},{"key":"3195_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ijpharm.2015.12.031","volume":"498","author":"J Shena","year":"2016","unstructured":"Shena J, Leea K, Choib S, Qub W, Wangb Y, Burgessa DJ. A reproducible accelerated in vitro release testing method for PLGA microspheres. Int J Pharm. 2016;498:274\u201382.","journal-title":"Int J Pharm"},{"issue":"12","key":"3195_CR46","first-page":"627","volume":"11","author":"H Park","year":"2019","unstructured":"Park H, Ha DH, Ha ES, Kim JS, Kim MS, Hwang SJ. Effect of stabilizers on encapsulation efficiency and release behavior of exenatide-loaded PLGA microsphere prepared by the W\/O\/W solvent evaporation method. Pharm. 2019;11(12):627.","journal-title":"Pharm"},{"key":"3195_CR47","doi-asserted-by":"publisher","first-page":"1249293","DOI":"10.3389\/fchem.2023.1249293","volume":"11","author":"Y Tai","year":"2023","unstructured":"Tai Y, Tian M, Chen Y, You P, Song X, Xu B, et al. Preparation of PLGA microspheres loaded with niclosamide via microfluidic technology and their inhibition of Caco-2 cell activity in vitro. Front Chem. 2023;11:1249293.","journal-title":"Front Chem"},{"issue":"3","key":"3195_CR48","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1208\/s12249-009-9280-8","volume":"10","author":"S Puthli","year":"2009","unstructured":"Puthli S, Vavia PR. Stability studies of microparticulate system with piroxicam as model drug. AAPS PharmSciTech. 2009;10(3):872\u201380.","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"3195_CR49","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1021\/mp200608y","volume":"9","author":"Y Liu","year":"2012","unstructured":"Liu Y, Schwendeman SP. Mapping microclimate pH distribution inside protein-encapsulated PLGA microspheres using confocal laser scanning microscopy. Mol Pharm. 2012;9(5):1342\u201350. https:\/\/doi.org\/10.1021\/mp200608y.","journal-title":"Mol Pharm"},{"issue":"11","key":"3195_CR50","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1021\/acs.molpharmaceut.0c00619","volume":"17","author":"A Beig","year":"2020","unstructured":"Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, et al. Physical-chemical characterization of octreotide encapsulated in commercial glucose-star PLGA microspheres. Mol Pharm. 2020;17(11):4141\u201351.","journal-title":"Mol Pharm"},{"issue":"20","key":"3195_CR51","doi-asserted-by":"publisher","first-page":"25869","DOI":"10.1021\/acsami.4c04010","volume":"16","author":"Z Gao","year":"2024","unstructured":"Gao Z, Wei Y, Ge J, Liu J, Qin Y, Gong F, et al. Development of 1 month sustained-release microspheres containing liraglutide for type 2 diabetes treatment. ACS Appl Mater Interfaces. 2024;16(20):25869\u201378.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3195_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10616-013-9664-1","volume":"67","author":"RT Pace","year":"2013","unstructured":"Pace RT, Burg KJL. Toxic effects of resazurin on cell cultures. Cytotechnology [Internet]. 2013;67(1):13.","journal-title":"Cytotechnology [Internet]"},{"issue":"44","key":"3195_CR53","doi-asserted-by":"publisher","first-page":"37452","DOI":"10.1039\/C6RA02994A","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Sun T, Zhang Y, Chaurasiya B, Huang L, Liu X, et al. Exenatide loaded PLGA microspheres for long-acting antidiabetic therapy: preparation, characterization, pharmacokinetics and pharmacodynamics. RSC Adv. 2016;6(44):37452\u201362.","journal-title":"RSC Adv"},{"key":"3195_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ejpb.2020.04.004","volume":"151","author":"R Wibel","year":"2020","unstructured":"Wibel R, Friedl JD, Zaichik S, Bernkop-Schn\u00fcrch A. Hydrophobic ion pairing (HIP) of (poly)peptide drugs: Benefits and drawbacks of different preparation methods. Eur J Pharm Biopharm. 2020;151:73\u201380.","journal-title":"Eur J Pharm Biopharm"},{"key":"3195_CR55","doi-asserted-by":"publisher","first-page":"122438","DOI":"10.1016\/j.ijpharm.2022.122438","volume":"630","author":"A Matteo J\u00f6rgensen","year":"2023","unstructured":"Matteo J\u00f6rgensen A, Knoll P, Haddadzadegan S, Fabian H, Hupfauf A, Gust R, et al. Biodegradable arginine based steroid-surfactants: Cationic green agents for hydrophobic ion-pairing. Int J Pharm. 2023;630:122438.","journal-title":"Int J Pharm"},{"issue":"9","key":"3195_CR56","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1021\/jf981370y","volume":"47","author":"P Busti","year":"1999","unstructured":"Busti P, Scarpeci S, Gatti CA, Delorenzi NJ. Interaction of alkylsulfonate ligands with \u03b2-lactoglobulin AB from bovine milk. J Agric Food Chem. 1999;47(9):3628\u201331.","journal-title":"J Agric Food Chem"},{"issue":"6","key":"3195_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3109\/02652048.2014.885606","volume":"31","author":"A Patel","year":"2014","unstructured":"Patel A, Gaudana R, Mitra AK. A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation. J Microencapsul. 2014;31(6):542\u201350.","journal-title":"J Microencapsul"},{"key":"3195_CR58","doi-asserted-by":"publisher","first-page":"106040","DOI":"10.1016\/j.ejps.2021.106040","volume":"167","author":"M Rabiei","year":"2021","unstructured":"Rabiei M, Kashanian S, Bahrami G, Derakhshankhah H, Barzegari E, Samavati SS, et al. Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity. Eur J Pharm Sci. 2021;167:106040.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3195_CR59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s40005-019-00439-x","volume":"49","author":"EM Elmowafy","year":"2019","unstructured":"Elmowafy EM, Tiboni M, Soliman ME. Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)\/poly(lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig. 2019;49(4):347\u201380.","journal-title":"J Pharm Investig"},{"issue":"1","key":"3195_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0378-5173(95)00002-Z","volume":"121","author":"T Niwa","year":"1995","unstructured":"Niwa T, Takeuchi H, Hino T, Nohara M, Kawashima Y. Biodegradable submicron carriers for peptide drugs: preparation of dl-lactide\/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. Int J Pharm. 1995;121(1):45\u201354.","journal-title":"Int J Pharm"},{"issue":"16","key":"3195_CR61","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.3390\/ijms22168884","volume":"22","author":"A Butreddy","year":"2021","unstructured":"Butreddy A, Gaddam RP, Kommineni N, Dudhipala N, Voshavar C. PLGA\/PLA-based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein\/peptide delivery. Int J Mol Sci. 2021;22(16):8884.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3195_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0169-409X(97)00050-1","volume":"28","author":"H Okada","year":"1997","unstructured":"Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev. 1997;28(1):43\u201370.","journal-title":"Adv Drug Deliv Rev"},{"key":"3195_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejpb.2023.06.017","volume":"190","author":"C Zhao","year":"2023","unstructured":"Zhao C, Zhu Z, Cao X, Pan F, Li F, Xue M, et al. Evaluation the injectability of injectable microparticle delivery systems on the basis of injection force and discharged rate. Eur J Pharm Biopharm. 2023;190:58\u201372.","journal-title":"Eur J Pharm Biopharm"},{"key":"3195_CR64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jddst.2018.03.024","volume":"45","author":"X Lin","year":"2018","unstructured":"Lin X, Yang H, Su L, Yang Z, Tang X. Effect of size on the in vitro\/in vivo drug release and degradation of exenatide-loaded PLGA microspheres. J Drug Deliv Sci Technol. 2018;45:346\u201356.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3195_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-031-12634-5_17","volume":"59","author":"F Jameel","year":"2023","unstructured":"Jameel F. Design of moisture specification studies for lyophilized product. AAPS Adv Pharm Sci Ser. 2023;59:307\u201313.","journal-title":"AAPS Adv Pharm Sci Ser"},{"key":"3195_CR66","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijbiomac.2019.08.185","volume":"140","author":"F Kahvand","year":"2019","unstructured":"Kahvand F, Fasihi M. Plasticizing and anti-plasticizing effects of polyvinyl alcohol in blend with thermoplastic starch. Int J Biol Macromol. 2019;140:775\u201381.","journal-title":"Int J Biol Macromol"},{"issue":"01","key":"3195_CR67","first-page":"57","volume":"2012","author":"OW Guirguis","year":"2011","unstructured":"Guirguis OW, Moselhey MTH. Thermal and structural studies of poly (vinyl alcohol) and hydroxypropyl cellulose blends. Nat Sci. 2011;2012(01):57\u201367.","journal-title":"Nat Sci"},{"issue":"28","key":"3195_CR68","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1039\/D3SM00082F","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu G, Martinez R, Bhatnagar A, McEnnis K. Influence of surfactant on glass transition temperature of poly(lactic-co-glycolic acid) nanoparticles. Soft Matter. 2023;19(28):5371\u20138.","journal-title":"Soft Matter"},{"issue":"01","key":"3195_CR69","first-page":"57","volume":"04","author":"OW Guirguis","year":"2012","unstructured":"Guirguis OW, Moselhey MTH. Thermal and structural studies of poly (vinyl alcohol) and hydroxypropyl cellulose blends. Nat Sci. 2012;04(01):57\u201367.","journal-title":"Nat Sci"},{"issue":"5","key":"3195_CR70","first-page":"405","volume":"10","author":"W Guo","year":"2015","unstructured":"Guo W, Quan P, Fang L, Cun D, Yang M. Sustained release donepezil loaded PLGA microspheres for injection: Preparation, in vitro and in vivo study. Asian J Pharm Sci. 2015;10(5):405\u201314.","journal-title":"Asian J Pharm Sci"},{"key":"3195_CR71","doi-asserted-by":"publisher","first-page":"123991","DOI":"10.1016\/j.ijpharm.2024.123991","volume":"654","author":"H Zeng","year":"2024","unstructured":"Zeng H, Song J, Li Y, Guo C, Zhang Y, Yin T, et al. Effect of hydroxyethyl starch on drug stability and release of semaglutide in PLGA microspheres. Int J Pharm. 2024;654:123991.","journal-title":"Int J Pharm"},{"key":"3195_CR72","doi-asserted-by":"crossref","unstructured":"Liu L, Zheng M, Liang R. Pharmaceutical Development and Technology ISSN: (Print) (Improvement of liraglutide release from PLGA microspheres by a porous microsphere-gel composite system Improvement of liraglutide release from PLGA microspheres by a porous microsphere-gel composite system. 2024.","DOI":"10.1080\/10837450.2024.2329763"},{"issue":"1","key":"3195_CR73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0021-9673(94)01257-F","volume":"705","author":"JK Towns","year":"1995","unstructured":"Towns JK. Moisture content in proteins: its effects and measurement. J Chromatogr A. 1995;705(1):115\u201327.","journal-title":"J Chromatogr A"},{"issue":"1\u20132","key":"3195_CR74","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0378-5173(02)00362-9","volume":"247","author":"S Zuleger","year":"2002","unstructured":"Zuleger S, Fassihi R, Lippold BC. Polymer particle erosion controlling drug release. II. Swelling investigations to clarify the release mechanism. Int J Pharm. 2002;247(1\u20132):23\u201337.","journal-title":"Int J Pharm"},{"key":"3195_CR75","unstructured":"Schutzman R. Mechanistic evaluation of early phases of drug release from polymer microparticles prepared by atomization techniques. 2023."},{"key":"3195_CR76","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jconrel.2016.03.011","volume":"228","author":"B Gu","year":"2016","unstructured":"Gu B, Sun X, Papadimitrakopoulos F, Burgess DJ. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere\/PVA hydrogel composites. J Control Release. 2016;228:170.","journal-title":"J Control Release"},{"issue":"1","key":"3195_CR77","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1080\/10717544.2017.1381200","volume":"24","author":"JZ Wu","year":"2017","unstructured":"Wu JZ, Williams GR, Li HY, Wang DX, De LS, Zhu LM. Insulin-loaded PLGA microspheres for glucose-responsive release. Drug Deliv. 2017;24(1):1513.","journal-title":"Drug Deliv"},{"issue":"3","key":"3195_CR78","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jconrel.2005.02.020","volume":"104","author":"KD Hinds","year":"2005","unstructured":"Hinds KD, Campbell KM, Holland KM, Lewis DH, Pich\u00e9 CA, Schmidt PG. PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis. J Control Release. 2005;104(3):447\u201360.","journal-title":"J Control Release"},{"key":"3195_CR79","unstructured":"APPLICATION NUMBER: 208232Orig1s000"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03195-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03195-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03195-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T16:04:08Z","timestamp":1758729848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03195-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":79,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["3195"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03195-4","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest in the present work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"199"}}